nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—HTR2A—enteric nervous system—Crohn's disease	0.0303	0.345	CbGeAlD
Zuclopenthixol—HTR2A—myenteric nerve plexus—Crohn's disease	0.023	0.262	CbGeAlD
Zuclopenthixol—Micturition disorder—Mesalazine—Crohn's disease	0.0195	0.0314	CcSEcCtD
Zuclopenthixol—Hepatitis cholestatic—Mesalazine—Crohn's disease	0.0162	0.0261	CcSEcCtD
Zuclopenthixol—Glucose tolerance impaired—Prednisone—Crohn's disease	0.0128	0.0206	CcSEcCtD
Zuclopenthixol—Pigmentation disorder—Prednisone—Crohn's disease	0.0103	0.0166	CcSEcCtD
Zuclopenthixol—Withdrawal symptom—Prednisone—Crohn's disease	0.00839	0.0135	CcSEcCtD
Zuclopenthixol—Feeling hot—Mesalazine—Crohn's disease	0.00829	0.0134	CcSEcCtD
Zuclopenthixol—Rhinorrhoea—Mesalazine—Crohn's disease	0.00803	0.013	CcSEcCtD
Zuclopenthixol—Breast disorder—Mercaptopurine—Crohn's disease	0.00786	0.0127	CcSEcCtD
Zuclopenthixol—Amenorrhoea—Mesalazine—Crohn's disease	0.00741	0.0119	CcSEcCtD
Zuclopenthixol—Skin discolouration—Mesalazine—Crohn's disease	0.0072	0.0116	CcSEcCtD
Zuclopenthixol—Pancytopenia—Mercaptopurine—Crohn's disease	0.00714	0.0115	CcSEcCtD
Zuclopenthixol—Drug withdrawal syndrome—Prednisone—Crohn's disease	0.00702	0.0113	CcSEcCtD
Zuclopenthixol—Blood bilirubin increased—Mesalazine—Crohn's disease	0.00688	0.0111	CcSEcCtD
Zuclopenthixol—Embolism venous—Prednisone—Crohn's disease	0.00682	0.011	CcSEcCtD
Zuclopenthixol—Abnormal dreams—Mesalazine—Crohn's disease	0.00643	0.0104	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00634	0.0102	CcSEcCtD
Zuclopenthixol—Menstruation irregular—Prednisone—Crohn's disease	0.00622	0.01	CcSEcCtD
Zuclopenthixol—DRD5—lymphoid tissue—Crohn's disease	0.00592	0.0674	CbGeAlD
Zuclopenthixol—Hypertonia—Mesalazine—Crohn's disease	0.0057	0.0092	CcSEcCtD
Zuclopenthixol—Immune system disorder—Mercaptopurine—Crohn's disease	0.00544	0.00877	CcSEcCtD
Zuclopenthixol—Malnutrition—Mercaptopurine—Crohn's disease	0.00524	0.00845	CcSEcCtD
Zuclopenthixol—Libido decreased—Mesalazine—Crohn's disease	0.00509	0.00821	CcSEcCtD
Zuclopenthixol—Increased appetite—Mesalazine—Crohn's disease	0.00503	0.00811	CcSEcCtD
Zuclopenthixol—Thirst—Mesalazine—Crohn's disease	0.00496	0.008	CcSEcCtD
Zuclopenthixol—Leukopenia—Mercaptopurine—Crohn's disease	0.00469	0.00757	CcSEcCtD
Zuclopenthixol—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00469	0.00756	CcSEcCtD
Zuclopenthixol—Migraine—Mesalazine—Crohn's disease	0.00465	0.0075	CcSEcCtD
Zuclopenthixol—Glaucoma—Prednisone—Crohn's disease	0.00457	0.00737	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00443	0.00715	CcSEcCtD
Zuclopenthixol—Liver function test abnormal—Mesalazine—Crohn's disease	0.00436	0.00703	CcSEcCtD
Zuclopenthixol—Breast disorder—Mesalazine—Crohn's disease	0.00427	0.00688	CcSEcCtD
Zuclopenthixol—Pancytopenia—Azathioprine—Crohn's disease	0.00426	0.00686	CcSEcCtD
Zuclopenthixol—Glycosuria—Prednisone—Crohn's disease	0.00425	0.00685	CcSEcCtD
Zuclopenthixol—Nasopharyngitis—Mesalazine—Crohn's disease	0.00422	0.00681	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00419	0.00675	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.00417	0.00672	CcSEcCtD
Zuclopenthixol—Skin disorder—Mercaptopurine—Crohn's disease	0.00415	0.0067	CcSEcCtD
Zuclopenthixol—Endocrine disorder—Prednisone—Crohn's disease	0.00415	0.0067	CcSEcCtD
Zuclopenthixol—Anorexia—Mercaptopurine—Crohn's disease	0.00408	0.00658	CcSEcCtD
Zuclopenthixol—Eosinophilia—Mesalazine—Crohn's disease	0.00404	0.00652	CcSEcCtD
Zuclopenthixol—Amenorrhoea—Prednisone—Crohn's disease	0.00392	0.00632	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.0039	0.00628	CcSEcCtD
Zuclopenthixol—Pancytopenia—Mesalazine—Crohn's disease	0.00388	0.00625	CcSEcCtD
Zuclopenthixol—Dysuria—Mesalazine—Crohn's disease	0.00382	0.00616	CcSEcCtD
Zuclopenthixol—Neutropenia—Mesalazine—Crohn's disease	0.00382	0.00616	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00378	0.00609	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Azathioprine—Crohn's disease	0.00373	0.00601	CcSEcCtD
Zuclopenthixol—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00373	0.00601	CcSEcCtD
Zuclopenthixol—Decreased appetite—Mercaptopurine—Crohn's disease	0.00372	0.006	CcSEcCtD
Zuclopenthixol—Weight increased—Mesalazine—Crohn's disease	0.00372	0.00599	CcSEcCtD
Zuclopenthixol—Weight decreased—Mesalazine—Crohn's disease	0.00369	0.00596	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00369	0.00596	CcSEcCtD
Zuclopenthixol—Jaundice—Mesalazine—Crohn's disease	0.00355	0.00572	CcSEcCtD
Zuclopenthixol—ADRA1A—epithelium—Crohn's disease	0.00354	0.0403	CbGeAlD
Zuclopenthixol—Sweating—Mesalazine—Crohn's disease	0.00349	0.00563	CcSEcCtD
Zuclopenthixol—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00344	0.00555	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Mesalazine—Crohn's disease	0.0034	0.00548	CcSEcCtD
Zuclopenthixol—Body temperature increased—Mercaptopurine—Crohn's disease	0.00338	0.00545	CcSEcCtD
Zuclopenthixol—Immune system disorder—Azathioprine—Crohn's disease	0.00324	0.00523	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Mesalazine—Crohn's disease	0.00323	0.0052	CcSEcCtD
Zuclopenthixol—Oedema peripheral—Mesalazine—Crohn's disease	0.00322	0.00519	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Mesalazine—Crohn's disease	0.00321	0.00518	CcSEcCtD
Zuclopenthixol—Arrhythmia—Azathioprine—Crohn's disease	0.0032	0.00517	CcSEcCtD
Zuclopenthixol—Urethral disorder—Mesalazine—Crohn's disease	0.0032	0.00517	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00315	0.00508	CcSEcCtD
Zuclopenthixol—Eye disorder—Mesalazine—Crohn's disease	0.00305	0.00492	CcSEcCtD
Zuclopenthixol—Tinnitus—Mesalazine—Crohn's disease	0.00305	0.00491	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Mesalazine—Crohn's disease	0.00303	0.00489	CcSEcCtD
Zuclopenthixol—Hyperkinesia—Prednisone—Crohn's disease	0.003	0.00484	CcSEcCtD
Zuclopenthixol—Angiopathy—Mesalazine—Crohn's disease	0.00296	0.00478	CcSEcCtD
Zuclopenthixol—Immune system disorder—Mesalazine—Crohn's disease	0.00295	0.00476	CcSEcCtD
Zuclopenthixol—Diarrhoea—Mercaptopurine—Crohn's disease	0.00293	0.00472	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Azathioprine—Crohn's disease	0.0029	0.00467	CcSEcCtD
Zuclopenthixol—Mental disorder—Mesalazine—Crohn's disease	0.00286	0.00462	CcSEcCtD
Zuclopenthixol—Erythema—Mesalazine—Crohn's disease	0.00284	0.00459	CcSEcCtD
Zuclopenthixol—Malaise—Azathioprine—Crohn's disease	0.00282	0.00454	CcSEcCtD
Zuclopenthixol—Flatulence—Mesalazine—Crohn's disease	0.0028	0.00452	CcSEcCtD
Zuclopenthixol—Leukopenia—Azathioprine—Crohn's disease	0.0028	0.00451	CcSEcCtD
Zuclopenthixol—Vascular purpura—Prednisone—Crohn's disease	0.00279	0.00451	CcSEcCtD
Zuclopenthixol—Tension—Mesalazine—Crohn's disease	0.00279	0.0045	CcSEcCtD
Zuclopenthixol—Nervousness—Mesalazine—Crohn's disease	0.00276	0.00446	CcSEcCtD
Zuclopenthixol—HRH1—epithelium—Crohn's disease	0.00274	0.0312	CbGeAlD
Zuclopenthixol—ADRA1A—lymphoid tissue—Crohn's disease	0.00272	0.031	CbGeAlD
Zuclopenthixol—Vomiting—Mercaptopurine—Crohn's disease	0.00272	0.00439	CcSEcCtD
Zuclopenthixol—Rash—Mercaptopurine—Crohn's disease	0.0027	0.00435	CcSEcCtD
Zuclopenthixol—Dermatitis—Mercaptopurine—Crohn's disease	0.00269	0.00435	CcSEcCtD
Zuclopenthixol—Vision blurred—Mesalazine—Crohn's disease	0.00268	0.00432	CcSEcCtD
Zuclopenthixol—Tremor—Mesalazine—Crohn's disease	0.00267	0.0043	CcSEcCtD
Zuclopenthixol—Amnesia—Prednisone—Crohn's disease	0.00266	0.00429	CcSEcCtD
Zuclopenthixol—Increased appetite—Prednisone—Crohn's disease	0.00266	0.00429	CcSEcCtD
Zuclopenthixol—Myalgia—Azathioprine—Crohn's disease	0.00266	0.00429	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00264	0.00426	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Mesalazine—Crohn's disease	0.00264	0.00426	CcSEcCtD
Zuclopenthixol—HRH1—smooth muscle tissue—Crohn's disease	0.00264	0.0301	CbGeAlD
Zuclopenthixol—Discomfort—Azathioprine—Crohn's disease	0.00263	0.00424	CcSEcCtD
Zuclopenthixol—Purpura—Prednisone—Crohn's disease	0.00259	0.00418	CcSEcCtD
Zuclopenthixol—Malaise—Mesalazine—Crohn's disease	0.00257	0.00414	CcSEcCtD
Zuclopenthixol—Vertigo—Mesalazine—Crohn's disease	0.00256	0.00412	CcSEcCtD
Zuclopenthixol—Syncope—Mesalazine—Crohn's disease	0.00255	0.00411	CcSEcCtD
Zuclopenthixol—Leukopenia—Mesalazine—Crohn's disease	0.00255	0.00411	CcSEcCtD
Zuclopenthixol—Nausea—Mercaptopurine—Crohn's disease	0.00254	0.0041	CcSEcCtD
Zuclopenthixol—Palpitations—Mesalazine—Crohn's disease	0.00251	0.00405	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Mesalazine—Crohn's disease	0.0025	0.00403	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Azathioprine—Crohn's disease	0.0025	0.00402	CcSEcCtD
Zuclopenthixol—Skin disorder—Azathioprine—Crohn's disease	0.00248	0.00399	CcSEcCtD
Zuclopenthixol—Hypertension—Mesalazine—Crohn's disease	0.00246	0.00396	CcSEcCtD
Zuclopenthixol—Myalgia—Mesalazine—Crohn's disease	0.00242	0.00391	CcSEcCtD
Zuclopenthixol—Anxiety—Mesalazine—Crohn's disease	0.00241	0.00389	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00241	0.00388	CcSEcCtD
Zuclopenthixol—Discomfort—Mesalazine—Crohn's disease	0.00239	0.00386	CcSEcCtD
Zuclopenthixol—Hypotension—Azathioprine—Crohn's disease	0.00238	0.00384	CcSEcCtD
Zuclopenthixol—HRH1—mammalian vulva—Crohn's disease	0.00238	0.0271	CbGeAlD
Zuclopenthixol—Dry mouth—Mesalazine—Crohn's disease	0.00237	0.00382	CcSEcCtD
Zuclopenthixol—ADRA2A—mammalian vulva—Crohn's disease	0.00233	0.0266	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00232	0.00374	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Mesalazine—Crohn's disease	0.00232	0.00374	CcSEcCtD
Zuclopenthixol—HTR2A—epithelium—Crohn's disease	0.00229	0.026	CbGeAlD
Zuclopenthixol—Shock—Mesalazine—Crohn's disease	0.00228	0.00368	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Mesalazine—Crohn's disease	0.00228	0.00367	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Mesalazine—Crohn's disease	0.00227	0.00367	CcSEcCtD
Zuclopenthixol—Tachycardia—Mesalazine—Crohn's disease	0.00227	0.00365	CcSEcCtD
Zuclopenthixol—Skin disorder—Mesalazine—Crohn's disease	0.00225	0.00364	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Mesalazine—Crohn's disease	0.00224	0.00362	CcSEcCtD
Zuclopenthixol—Anorexia—Mesalazine—Crohn's disease	0.00221	0.00357	CcSEcCtD
Zuclopenthixol—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.0022	0.00355	CcSEcCtD
Zuclopenthixol—HTR2A—smooth muscle tissue—Crohn's disease	0.0022	0.0251	CbGeAlD
Zuclopenthixol—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.0022	0.00355	CcSEcCtD
Zuclopenthixol—Hypotension—Mesalazine—Crohn's disease	0.00217	0.0035	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00212	0.00341	CcSEcCtD
Zuclopenthixol—Sweating increased—Prednisone—Crohn's disease	0.0021	0.00339	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Azathioprine—Crohn's disease	0.0021	0.00339	CcSEcCtD
Zuclopenthixol—Insomnia—Mesalazine—Crohn's disease	0.0021	0.00339	CcSEcCtD
Zuclopenthixol—Paraesthesia—Mesalazine—Crohn's disease	0.00208	0.00336	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00208	0.00336	CcSEcCtD
Zuclopenthixol—HRH1—digestive system—Crohn's disease	0.00208	0.0237	CbGeAlD
Zuclopenthixol—Dyspnoea—Mesalazine—Crohn's disease	0.00207	0.00334	CcSEcCtD
Zuclopenthixol—Somnolence—Mesalazine—Crohn's disease	0.00206	0.00333	CcSEcCtD
Zuclopenthixol—Dyspepsia—Mesalazine—Crohn's disease	0.00204	0.0033	CcSEcCtD
Zuclopenthixol—Neutropenia—Prednisone—Crohn's disease	0.00202	0.00326	CcSEcCtD
Zuclopenthixol—Decreased appetite—Mesalazine—Crohn's disease	0.00202	0.00325	CcSEcCtD
Zuclopenthixol—Abdominal pain—Azathioprine—Crohn's disease	0.00201	0.00325	CcSEcCtD
Zuclopenthixol—Body temperature increased—Azathioprine—Crohn's disease	0.00201	0.00325	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.002	0.00323	CcSEcCtD
Zuclopenthixol—Fatigue—Mesalazine—Crohn's disease	0.002	0.00323	CcSEcCtD
Zuclopenthixol—Erectile dysfunction—Prednisone—Crohn's disease	0.00199	0.00321	CcSEcCtD
Zuclopenthixol—Constipation—Mesalazine—Crohn's disease	0.00199	0.0032	CcSEcCtD
Zuclopenthixol—Pain—Mesalazine—Crohn's disease	0.00199	0.0032	CcSEcCtD
Zuclopenthixol—Weight increased—Prednisone—Crohn's disease	0.00197	0.00317	CcSEcCtD
Zuclopenthixol—Weight decreased—Prednisone—Crohn's disease	0.00195	0.00315	CcSEcCtD
Zuclopenthixol—Hyperglycaemia—Prednisone—Crohn's disease	0.00195	0.00314	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Mesalazine—Crohn's disease	0.00191	0.00309	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Mesalazine—Crohn's disease	0.0019	0.00306	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Azathioprine—Crohn's disease	0.00188	0.00303	CcSEcCtD
Zuclopenthixol—Abdominal pain—Mesalazine—Crohn's disease	0.00184	0.00296	CcSEcCtD
Zuclopenthixol—Body temperature increased—Mesalazine—Crohn's disease	0.00184	0.00296	CcSEcCtD
Zuclopenthixol—Diarrhoea—Azathioprine—Crohn's disease	0.00174	0.00281	CcSEcCtD
Zuclopenthixol—HTR2A—digestive system—Crohn's disease	0.00174	0.0198	CbGeAlD
Zuclopenthixol—Hypersensitivity—Mesalazine—Crohn's disease	0.00171	0.00276	CcSEcCtD
Zuclopenthixol—Connective tissue disorder—Prednisone—Crohn's disease	0.0017	0.00274	CcSEcCtD
Zuclopenthixol—Dizziness—Azathioprine—Crohn's disease	0.00169	0.00272	CcSEcCtD
Zuclopenthixol—Asthenia—Mesalazine—Crohn's disease	0.00167	0.00269	CcSEcCtD
Zuclopenthixol—Pruritus—Mesalazine—Crohn's disease	0.00164	0.00265	CcSEcCtD
Zuclopenthixol—Vomiting—Azathioprine—Crohn's disease	0.00162	0.00261	CcSEcCtD
Zuclopenthixol—Eye disorder—Prednisone—Crohn's disease	0.00162	0.00261	CcSEcCtD
Zuclopenthixol—Rash—Azathioprine—Crohn's disease	0.00161	0.00259	CcSEcCtD
Zuclopenthixol—Dermatitis—Azathioprine—Crohn's disease	0.00161	0.00259	CcSEcCtD
Zuclopenthixol—Headache—Azathioprine—Crohn's disease	0.0016	0.00257	CcSEcCtD
Zuclopenthixol—Diarrhoea—Mesalazine—Crohn's disease	0.00159	0.00256	CcSEcCtD
Zuclopenthixol—CYP2D6—digestive system—Crohn's disease	0.00158	0.0181	CbGeAlD
Zuclopenthixol—Angiopathy—Prednisone—Crohn's disease	0.00157	0.00253	CcSEcCtD
Zuclopenthixol—Immune system disorder—Prednisone—Crohn's disease	0.00156	0.00252	CcSEcCtD
Zuclopenthixol—Arrhythmia—Prednisone—Crohn's disease	0.00154	0.00249	CcSEcCtD
Zuclopenthixol—Dizziness—Mesalazine—Crohn's disease	0.00154	0.00248	CcSEcCtD
Zuclopenthixol—Mental disorder—Prednisone—Crohn's disease	0.00151	0.00244	CcSEcCtD
Zuclopenthixol—Nausea—Azathioprine—Crohn's disease	0.00151	0.00244	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—Crohn's disease	0.0015	0.00243	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—Crohn's disease	0.0015	0.00243	CcSEcCtD
Zuclopenthixol—Vomiting—Mesalazine—Crohn's disease	0.00148	0.00238	CcSEcCtD
Zuclopenthixol—Rash—Mesalazine—Crohn's disease	0.00146	0.00236	CcSEcCtD
Zuclopenthixol—Dermatitis—Mesalazine—Crohn's disease	0.00146	0.00236	CcSEcCtD
Zuclopenthixol—Headache—Mesalazine—Crohn's disease	0.00145	0.00235	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisone—Crohn's disease	0.00142	0.00229	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Prednisone—Crohn's disease	0.0014	0.00225	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—Crohn's disease	0.00138	0.00223	CcSEcCtD
Zuclopenthixol—Nausea—Mesalazine—Crohn's disease	0.00138	0.00222	CcSEcCtD
Zuclopenthixol—Malaise—Prednisone—Crohn's disease	0.00136	0.00219	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—Crohn's disease	0.00135	0.00218	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—Crohn's disease	0.00135	0.00218	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisone—Crohn's disease	0.00132	0.00213	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisone—Crohn's disease	0.0013	0.0021	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—Crohn's disease	0.0013	0.0021	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—Crohn's disease	0.00128	0.00207	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—Crohn's disease	0.00128	0.00206	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00127	0.00205	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisone—Crohn's disease	0.00127	0.00204	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—Crohn's disease	0.00123	0.00198	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—Crohn's disease	0.00121	0.00195	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—Crohn's disease	0.0012	0.00194	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—Crohn's disease	0.0012	0.00193	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—Crohn's disease	0.00119	0.00192	CcSEcCtD
Zuclopenthixol—HRH1—lymph node—Crohn's disease	0.00119	0.0136	CbGeAlD
Zuclopenthixol—Hyperhidrosis—Prednisone—Crohn's disease	0.00119	0.00191	CcSEcCtD
Zuclopenthixol—Anorexia—Prednisone—Crohn's disease	0.00117	0.00189	CcSEcCtD
Zuclopenthixol—ADRA2A—lymph node—Crohn's disease	0.00117	0.0133	CbGeAlD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00112	0.0018	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisone—Crohn's disease	0.00111	0.00179	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisone—Crohn's disease	0.0011	0.00178	CcSEcCtD
Zuclopenthixol—Dyspepsia—Prednisone—Crohn's disease	0.00108	0.00174	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—Crohn's disease	0.00107	0.00172	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—Crohn's disease	0.00106	0.00171	CcSEcCtD
Zuclopenthixol—Constipation—Prednisone—Crohn's disease	0.00105	0.00169	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisone—Crohn's disease	0.00101	0.00163	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—Crohn's disease	0.001	0.00162	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—Crohn's disease	0.000971	0.00157	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—Crohn's disease	0.000971	0.00157	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisone—Crohn's disease	0.000905	0.00146	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—Crohn's disease	0.000881	0.00142	CcSEcCtD
Zuclopenthixol—Pruritus—Prednisone—Crohn's disease	0.000869	0.0014	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—Crohn's disease	0.00084	0.00136	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—Crohn's disease	0.000812	0.00131	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—Crohn's disease	0.000781	0.00126	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—Crohn's disease	0.000774	0.00125	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—Crohn's disease	0.000774	0.00125	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—Crohn's disease	0.000769	0.00124	CcSEcCtD
Zuclopenthixol—Nausea—Prednisone—Crohn's disease	0.00073	0.00118	CcSEcCtD
Zuclopenthixol—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000213	0.00073	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	0.000211	0.000724	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCR6—Crohn's disease	0.000209	0.000715	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RIPK2—Crohn's disease	0.000208	0.000712	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	0.000206	0.000704	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR9—Crohn's disease	0.000205	0.000701	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—IL2RA—Crohn's disease	0.000204	0.0007	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL3—Crohn's disease	0.000203	0.000694	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—PTGER4—Crohn's disease	0.000202	0.000692	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR9—Crohn's disease	0.000202	0.00069	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR9—Crohn's disease	0.000201	0.000688	CbGpPWpGaD
Zuclopenthixol—DRD1—Circadian rythm related genes—IL6—Crohn's disease	0.000201	0.000687	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	0.0002	0.000686	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000199	0.000682	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000199	0.000681	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	0.000199	0.00068	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	0.000197	0.000675	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—RASGRP1—Crohn's disease	0.000196	0.000671	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000195	0.000667	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—FADS1—Crohn's disease	0.000192	0.000656	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR ligand binding—CXCL8—Crohn's disease	0.000191	0.000654	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—GPR65—Crohn's disease	0.00019	0.000652	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL3—Crohn's disease	0.00019	0.000649	CbGpPWpGaD
Zuclopenthixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000189	0.000648	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RBX1—Crohn's disease	0.000189	0.000646	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.000189	0.000645	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—IL2RA—Crohn's disease	0.000188	0.000644	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—GPR65—Crohn's disease	0.000187	0.000641	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—GPR65—Crohn's disease	0.000187	0.00064	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL3—Crohn's disease	0.000187	0.000639	CbGpPWpGaD
Zuclopenthixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000186	0.000638	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL3—Crohn's disease	0.000186	0.000637	CbGpPWpGaD
Zuclopenthixol—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000186	0.000637	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL2RA—Crohn's disease	0.000186	0.000635	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—PTGER4—Crohn's disease	0.000184	0.000629	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	0.000183	0.000628	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000183	0.000628	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	0.000183	0.000628	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	0.000183	0.000626	CbGpPWpGaD
Zuclopenthixol—HTR2A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000183	0.000625	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000182	0.000625	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.000181	0.00062	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00018	0.000618	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00018	0.000617	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCR6—Crohn's disease	0.00018	0.000615	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GPX4—Crohn's disease	0.000179	0.000614	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—JAK2—Crohn's disease	0.000178	0.000609	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SOCS1—Crohn's disease	0.000178	0.000608	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000177	0.000605	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000176	0.000602	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—GCKR—Crohn's disease	0.000173	0.000593	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL3—Crohn's disease	0.000172	0.00059	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	0.00017	0.000583	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	0.00017	0.000581	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00017	0.00058	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL3—Crohn's disease	0.000169	0.00058	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—TYK2—Crohn's disease	0.000169	0.00058	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL3—Crohn's disease	0.000169	0.000579	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—RASGRP1—Crohn's disease	0.000167	0.00057	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	0.000166	0.000568	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—UBE2D1—Crohn's disease	0.000166	0.000567	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000164	0.000562	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000164	0.000561	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000164	0.00056	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RBX1—Crohn's disease	0.000163	0.000556	CbGpPWpGaD
Zuclopenthixol—DRD5—GPCR downstream signaling—CXCL8—Crohn's disease	0.000162	0.000556	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—JAK2—Crohn's disease	0.000162	0.000553	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RIPK2—Crohn's disease	0.000161	0.00055	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.00016	0.000549	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.00016	0.000549	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2RA—Crohn's disease	0.00016	0.000547	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—PTGER4—Crohn's disease	0.000158	0.000542	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL3—Crohn's disease	0.000157	0.000536	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	0.000154	0.000528	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—SMAD3—Crohn's disease	0.000153	0.000525	CbGpPWpGaD
Zuclopenthixol—DRD2—Circadian rythm related genes—IL6—Crohn's disease	0.000152	0.000519	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—RASGRP1—Crohn's disease	0.000151	0.000518	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000149	0.00051	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—CXCL8—Crohn's disease	0.000148	0.000505	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR ligand binding—CXCL8—Crohn's disease	0.000144	0.000494	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—UBE2D1—Crohn's disease	0.000143	0.000488	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2RA—Crohn's disease	0.000142	0.000486	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000142	0.000486	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	0.000142	0.000485	CbGpPWpGaD
Zuclopenthixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000141	0.000484	CbGpPWpGaD
Zuclopenthixol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000141	0.000483	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000139	0.000476	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000138	0.000474	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RIPK2—Crohn's disease	0.000138	0.000473	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—JAK2—Crohn's disease	0.000137	0.00047	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SOCS1—Crohn's disease	0.000137	0.00047	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—ALB—Crohn's disease	0.000136	0.000466	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR6—Crohn's disease	0.000136	0.000464	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL3—Crohn's disease	0.000135	0.000461	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR6—Crohn's disease	0.000133	0.000457	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR6—Crohn's disease	0.000133	0.000456	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2RA—Crohn's disease	0.000133	0.000455	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—TYK2—Crohn's disease	0.000131	0.000448	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000131	0.000447	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	0.000131	0.000447	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	0.00013	0.000447	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—RASGRP1—Crohn's disease	0.00013	0.000446	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000129	0.000442	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000128	0.000438	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—JAK2—Crohn's disease	0.000126	0.000433	CbGpPWpGaD
Zuclopenthixol—HTR6—GPCR downstream signaling—CXCL8—Crohn's disease	0.000125	0.000429	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—FADS1—Crohn's disease	0.000125	0.000428	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—JAK2—Crohn's disease	0.000125	0.000427	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RBX1—Crohn's disease	0.000123	0.00042	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	0.000121	0.000416	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RBX1—Crohn's disease	0.000121	0.000413	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2RA—Crohn's disease	0.000121	0.000413	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RBX1—Crohn's disease	0.00012	0.000412	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTGER4—Crohn's disease	0.000119	0.000409	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000119	0.000407	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000119	0.000406	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	0.000118	0.000405	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—SMAD3—Crohn's disease	0.000118	0.000405	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—JAK2—Crohn's disease	0.000118	0.000405	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	0.000118	0.000405	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SOCS1—Crohn's disease	0.000118	0.000404	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTGER4—Crohn's disease	0.000118	0.000402	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTGER4—Crohn's disease	0.000117	0.000401	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GPX4—Crohn's disease	0.000117	0.0004	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000116	0.000398	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	0.000115	0.000394	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—CXCL8—Crohn's disease	0.000114	0.00039	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—GCKR—Crohn's disease	0.000113	0.000387	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—TYK2—Crohn's disease	0.000113	0.000385	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	0.00011	0.000376	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2RA—Crohn's disease	0.00011	0.000375	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000108	0.00037	CbGpPWpGaD
Zuclopenthixol—DRD1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000108	0.00037	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—UBE2D1—Crohn's disease	0.000108	0.000368	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—JAK2—Crohn's disease	0.000107	0.000368	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	0.000107	0.000366	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000106	0.000362	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	0.000106	0.000362	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RIPK2—Crohn's disease	0.000104	0.000357	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000104	0.000355	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	0.000103	0.000351	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RIPK2—Crohn's disease	0.000102	0.000351	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—SMAD3—Crohn's disease	0.000102	0.000349	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL3—Crohn's disease	0.000102	0.000348	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.000101	0.000344	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL3—Crohn's disease	0.0001	0.000343	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TYK2—Crohn's disease	0.0001	0.000343	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL3—Crohn's disease	9.99e-05	0.000342	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	9.84e-05	0.000337	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	9.8e-05	0.000336	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL3—Crohn's disease	9.8e-05	0.000336	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	9.68e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	9.66e-05	0.000331	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	9.63e-05	0.00033	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—JAK2—Crohn's disease	9.55e-05	0.000327	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	9.48e-05	0.000325	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2RA—Crohn's disease	9.44e-05	0.000323	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	9.34e-05	0.00032	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL3—Crohn's disease	9.11e-05	0.000312	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	8.93e-05	0.000306	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SOCS1—Crohn's disease	8.92e-05	0.000305	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	8.81e-05	0.000302	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	8.79e-05	0.000301	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	8.77e-05	0.0003	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	8.77e-05	0.0003	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SOCS1—Crohn's disease	8.75e-05	0.0003	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCL8—Crohn's disease	8.72e-05	0.000298	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	8.6e-05	0.000295	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	8.59e-05	0.000294	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TYK2—Crohn's disease	8.5e-05	0.000291	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	8.36e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TYK2—Crohn's disease	8.35e-05	0.000286	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—Crohn's disease	8.29e-05	0.000284	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	8.19e-05	0.00028	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	8.15e-05	0.000279	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—JAK2—Crohn's disease	8.11e-05	0.000278	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	8.02e-05	0.000275	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	8e-05	0.000274	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	7.99e-05	0.000274	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	7.98e-05	0.000273	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	7.98e-05	0.000273	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—JAK2—Crohn's disease	7.96e-05	0.000273	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	7.85e-05	0.000269	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	7.81e-05	0.000267	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TYK2—Crohn's disease	7.73e-05	0.000264	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SMAD3—Crohn's disease	7.7e-05	0.000263	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	7.61e-05	0.00026	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	7.57e-05	0.000259	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SMAD3—Crohn's disease	7.56e-05	0.000259	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	7.42e-05	0.000254	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	7.4e-05	0.000253	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—JAK2—Crohn's disease	7.37e-05	0.000252	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	7.3e-05	0.00025	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	7.28e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	7.27e-05	0.000249	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	7.26e-05	0.000248	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	7.13e-05	0.000244	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2RA—Crohn's disease	7.13e-05	0.000244	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	7.01e-05	0.00024	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—STAT3—Crohn's disease	7.01e-05	0.00024	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2RA—Crohn's disease	7e-05	0.00024	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	6.89e-05	0.000236	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	6.87e-05	0.000235	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCL8—Crohn's disease	6.73e-05	0.00023	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TYK2—Crohn's disease	6.65e-05	0.000228	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	6.63e-05	0.000227	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—Crohn's disease	6.4e-05	0.000219	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	6.38e-05	0.000218	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—JAK2—Crohn's disease	6.34e-05	0.000217	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL8—Crohn's disease	5.79e-05	0.000198	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—Crohn's disease	5.52e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—Crohn's disease	5.51e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—STAT3—Crohn's disease	5.41e-05	0.000185	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TYK2—Crohn's disease	5.02e-05	0.000172	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TYK2—Crohn's disease	4.94e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TYK2—Crohn's disease	4.93e-05	0.000169	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—Crohn's disease	4.9e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	4.84e-05	0.000166	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—Crohn's disease	4.83e-05	0.000165	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—JAK2—Crohn's disease	4.79e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—JAK2—Crohn's disease	4.71e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—JAK2—Crohn's disease	4.7e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—STAT3—Crohn's disease	4.66e-05	0.000159	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	4.62e-05	0.000158	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	4.5e-05	0.000154	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL8—Crohn's disease	4.37e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	4.3e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL8—Crohn's disease	4.29e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	4.29e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	4.21e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—Crohn's disease	4.16e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—Crohn's disease	4.09e-05	0.00014	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—Crohn's disease	4.08e-05	0.00014	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	4.01e-05	0.000137	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	3.91e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—Crohn's disease	3.78e-05	0.000129	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	3.72e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—Crohn's disease	3.59e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—STAT3—Crohn's disease	3.52e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT3—Crohn's disease	3.46e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT3—Crohn's disease	3.45e-05	0.000118	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	3.39e-05	0.000116	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—Crohn's disease	3.25e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	3.15e-05	0.000108	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—Crohn's disease	3.14e-05	0.000108	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—Crohn's disease	2.46e-05	8.41e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—Crohn's disease	2.42e-05	8.27e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—Crohn's disease	2.41e-05	8.25e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—Crohn's disease	2.37e-05	8.1e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—Crohn's disease	2.2e-05	7.53e-05	CbGpPWpGaD
